Skip to content

A study to evaluate the effect of food ingredient in healthy adult on the suppression of blood glucose elevation -crossover comparison study-

A study to evaluate the effect of food ingredient in healthy adult on the suppression of blood glucose elevation - A study to evaluate the effect of food ingredient in healthy adult on the suppression of blood glucose elevation -crossover comparison study-

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047736
Enrollment
12
Registered
2022-05-31
Start date
2022-05-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Ingestion of test food(research food1) Ingestion of test food(research food2) Ingestion of placebo

Sponsors

Kewpie Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Kewpie Co., Ltd. employees who voluntarily wish to participate in the study and provide written consent (2) Men and women between the ages of 20 and 50 who are healthy and are not being treated for a disease (3) Subjects who are able to maintain a certain daily lifestyle during the study period

Exclusion criteria

Exclusion criteria: (1) Subjects who suffer from serious diseases (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) or mental illness (2) Subjects with a history of serious diseases (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) in the past (3) Subjects who are unable to maintain their daily lifestyle due to significant changes in diet and physical activity (4) Subjects with possible food allergy or drug allergy to the test food (5) Subjects who consume food for specified health use, health food, etc. on a daily basis (6) Subjects who are otherwise deemed ineligible by the investigator to participate in this study

Design outcomes

Primary

MeasureTime frame
blood glucose

Secondary

MeasureTime frame
Insulin, GLP-1

Countries

Japan

Contacts

Public ContactTomomi Tanaka

Kewpie Corporation R&D Division

tomomi_tanaka@kewpie.co.jp03-5384-7759

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026